Skip to main content
Premium Trial:

Request an Annual Quote

Hexagon Bio Raises $61M in Private Financing Round

NEW YORK — Drug discovery company Hexagon Bio said on Wednesday that it has raised $61 million in private financing.

The funding round was led by Nextech Invest with participation from new investors SoftBank Vision Fund 2* and Casdin Capital and existing investors The Column Group, 8VC, and Two Sigma Ventures.

Hexagon has developed a platform that combines machine learning, genomics, synthetic biology, and automation to identify therapeutic small molecules and their protein targets directly from microbial genomes. With the new funding, the firm aims to expand its microbial genomics database and accelerate its drug discovery efforts, with an initial focus on infectious disease and cancer.

"Microbial genomes are an incredibly rich source of diverse, potent, and drug-like compounds that, as a result of millions of years of evolution, provide elegant solutions to human therapeutic targets that have eluded traditional screening approaches," Hexagon cofounder and CEO Maureen Hillenmeyer said in a statement.

About a year ago, Menlo Park, California-based Hexagon raised $47 million in a Series A round.

The Scan

Genetic Ancestry of South America's Indigenous Mapuche Traced

Researchers in Current Biology analyzed genome-wide data from more than five dozen Mapuche individuals to better understand their genetic history.

Study Finds Variants Linked to Diverticular Disease, Presents Polygenic Score

A new study in Cell Genomics reports on more than 150 genetic variants associated with risk of diverticular disease.

Mild, Severe Psoriasis Marked by Different Molecular Features, Spatial Transcriptomic Analysis Finds

A spatial transcriptomics paper in Science Immunology finds differences in cell and signaling pathway activity between mild and severe psoriasis.

ChatGPT Does As Well As Humans Answering Genetics Questions, Study Finds

Researchers in the European Journal of Human Genetics had ChatGPT answer genetics-related questions, finding it was about 68 percent accurate, but sometimes gave different answers to the same question.